Native Staphylococcus aureus Staphopain B
Unit Price:
Get Latest Price
CAS No.:
347841-89-8
Content:
95%
Sample Available:
Yes
Price valid (until):
2026-11-17
Company Type:
Manufactory
Location:
United States
Payment Terms:
TT against copy of documents,D/P
Average Lead Time:
15 days
Qualification:
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Description
ProductName Native Staphylococcus aureus Staphopain B Cat No NATE-0683 Description Staphopains A and B are part of the staphylococcal proteolytic cascade (SPC) and may contribute to tissue invasion and metastatic infections of Staphylococcus aureus. Staphopain A, along with Staphopain B, may contribute to septic shock through the release of bradykinin and S-kinin from human kininogens. This activity required proteolytically-active Staphopain A and was augmented by Staphopain B. Abbr sspB, Native (Staphylococcus aureus) Alias sspB Source Staphylococcus aureus Product Overview Staphopain activity is inhbited by staphostatin B (sspC) and E-64. Staphopain activity is stimulated by EDTA.. Staphopain A and Staphopain B, members of the peptidase C47 family, are the major cysteine proteases secreted by S. aureus. Enzyme Commission Number EC 3.4.22.48 CAS No 347841-89-8 Molecular Weight mol wt ~20 kDa by SDS-PAGE Purity > 95% (SDS-PAGE) Storage −20°C Warnings Lyophilized from a solution containing 25 mM sodium acetate pH 5.5, 100 mM NaCl, and 0.5 mM EDTA. Each vial contains 0.1 mg of protein. Reconstitute with 0.2 mLs of water to create a 0.5 mg/mL solution. Synonyms Staphopain; EC 3.4.22.48; staphylopain; 347841-89-8; Staphopain B; Staphylococcal cysteine proteinase B; Staphylopain B; sspB category Specialty Chemicals(c26) cas_num 347841-89-8 Basic Info-
Product Name:
Staphopain B
CAS No.:347841-89-8
Categories:
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
